| (HKD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 177.25M | — |
| Operating expense | — | — |
| Net income | -211.42M | -29.81% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 9887.HK returned +2.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +39.4% |
| 1 year | +2.5% |
| All-time high | $80.00 (Apr 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in 9887.HK would be worth today ›No. Nanjing Leads Biolabs Co., Ltd. has not paid a dividend in the past 12 months.
Nanjing Leads Biolabs Co., Ltd. is part of the Healthcare sector.
Nanjing Leads Biolabs Co., Ltd. has a market cap of 13.73B HKD, based on the latest quote.
